Muro, K., Uetake, H., Tsuchihara, K., Shitara, K., Yamazaki, K., Ota, M., Oki, E., Sato, T., Naitoh, T., Komatsu, Y., Kato, T., Yamanaka, K., Mori, I., Soeda, J., Hihara, M., Yamanaka, T., Akagi, K., Ochiai, A., & Yoshino, T. (n.d.). p-034PARADIGM study: A multicenter, randomized, phase III study of mFOLFOX6 plus panitumumab or bevacizumab as first-line treatment in patients with RAS (KRAS/NRAS) wild-type metastatic colorectal cancer. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100094625064.0x00004c